Building on our previous finding that treatment with P. aeruginosa strain PAO1 supplemented with Pf phage reduced pulmonary inflammation in response to bacterial infection (Secor et al., 2017), we examined P. aeruginosa infection in the absence of Pf4 phage. Here, PF4 is linked to bacterial infectious disease.